Violation Tracker Parent Company Summary
Parent Company Name:
Johnson & Johnson
Ownership Structure:
publicly traded (ticker symbol JNJ)
Headquartered in:
New Jersey
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$4,248,447,763
Number of records:
58
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
|---|---|---|
| healthcare-related offenses | $3,136,511,000 | 11 |
| government-contracting-related offenses | $558,705,368 | 12 |
| safety-related offenses | $411,310,781 | 17 |
| competition-related offenses | $130,450,000 | 4 |
| consumer-protection-related offenses | $5,769,000 | 5 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
|---|---|---|
| off-label or unapproved promotion of medical products | $3,136,000,000 | 10 |
| False Claims Act and related | $558,705,368 | 12 |
| drug or medical equipment safety violation | $411,269,800 | 12 |
| Foreign Corrupt Practices Act | $70,450,000 | 3 |
| price-fixing or anti-competitive practices | $60,000,000 | 1 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links:
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency |
Penalty Amount |
|---|---|---|---|---|
| Johnson & Johnson | environmental violation | 2004 | EPA | $5,000 |
| ETHICON INC | environmental violation | 2009 | NJ-ENV | $5,250 |
| ETHICON ENDO SURGERY | aviation safety violation | 2010 | FAA | $5,500 |
| ETHICON, INC. | workplace safety or health violation | 2017 | OSHA | $6,518 |
| Janssen Pharmaceutica Inc. | environmental violation | 2004 | EPA | $7,700 |
| JOHNSON & JOHNSON CONSUMER, INC. | workplace safety or health violation | 2018 | OSHA | $7,853 |
| ETHICON, INC. | workplace safety or health violation | 2020 | OSHA | $9,832 |
| STERILMED, INC. | workplace safety or health violation | 2006 | OSHA | $11,278 |
| Advanced Sterilization Products | environmental violation | 2012 | CA-DPR | $25,616 |
| McNeil-PPC, Inc. | consumer protection violation | 2004 | NY-AG | $52,000 |
| Janssen Pharmaceutical (SB) | environmental violation | 2010 | EPA | $105,000 |
| Advanced Sterilization Products | environmental violation | 2014 | EPA | $136,800 |
| Advanced Sterilization Products, Div of Ethicon | environmental violation | 2014 | EPA | (*) $136,800 |
| Synthes, Inc. | consumer protection violation | 2009 | NJ-AG | $236,000 |
| Neutrogena Corp. | environmental violation | 2014 | CA-DTSC | $416,248 |
| Micrus Corporation | Foreign Corrupt Practices Act | 2005 | DOJ_CRIMINAL | $450,000 |
| McNeil-PPC Inc. | consumer protection violation | 2015 | AL-AG | $500,000 |
| Johnson & Johnson | consumer protection violation | 2015 | CA-MULTI | $506,000 |
| Johnson & Johnson | Controlled Substances Act violation | 2008 | USAO | $511,000 |
| Synthes Inc. | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
| Advanced Sterilization Products, a division of Ethicon Inc. | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
| Johnson & Johnson, Janssen Pharmaceutical Products LP, Ortho-McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP, McNeil-PPC, Inc. and Centocor, Inc. | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
| Ortho McNeil Pharmaceutical | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
| Ortho-McNeil Pharmaceutical, Inc. | False Claims Act and related | 2009 | MULTI-AG | (*) $3,400,000 |
| Johnson & Johnson Medical, Inc. | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
| Johnson & Johnson | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
| DePuy Orthopaedics Inc. | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
| Johnson and Johnson | consumer protection violation | 2009 | WV-AG | $4,475,000 |
| Synthes USA | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
| Johnson & Johnson et al. | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
| Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
| Ortho-McNeil Pharmaceutical LLC | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
| Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
| Johnson & Johnson | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
| Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
| Lifescan, Inc. | False Claims Act and related | 2001 | DOJ_CIVIL | $15,000,000 |
| Janssen Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2013 | MA-AG | $15,100,000 |
| Acclarent Inc. | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
| Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
| Ortho-McNeil Pharmaceutical LLC | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*) $24,681,516 |
| McNeil-PPC Inc. | drug or medical equipment safety violation | 2015 | FDA | $25,000,000 |
| LifeScan, Inc. | drug or medical equipment safety violation | 2003 | MULTI-AG | $30,600,000 |
| Johnson & Johnson | drug or medical equipment safety violation | 2017 | MULTI-AG | $33,000,000 |
| Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
| Johnson & Johnson | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
| LifeScan Inc. | drug or medical equipment safety violation | 2000 | USAO | $60,000,000 |
| Johnson & Johnson Vision Care, Inc. | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| Ortho-McNeil Pharmaceutical LLC | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
| Depuy Orthopaedics Inc. | False Claims Act and related | 2007 | USAO | $84,700,000 |
| Scios Inc. | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
| Johnson & Johnson | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
| Johnson & Johnson | drug or medical equipment safety violation | 2019 | MULTI-AG | $120,000,000 |
| Johnson & Johnson | off-label or unapproved promotion of medical products | 2012 | TX-AG | $158,000,000 |
| Janssen Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
| Actelion Pharmaceuticals US, Inc. | False Claims Act and related | 2018 | DOJ_CIVIL | $360,000,000 |
| Janssen Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*) $541,000,000 |
| Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
